Brand Intelligence Graph
Company Overview
About Aktis Oncology
Aktis Oncology is a Boston-based clinical-stage oncology company developing alpha-emitting radiopharmaceuticals against prevalent solid tumors. The company completed a $318 million IPO in January 2026 — the first significant biotech IPO of 2026 — pricing 17.65 million shares at $18 each on the Nasdaq under ticker AKTS. Eli Lilly stepped in to purchase $100 million of the offering.
Business Model & Competitive Advantage
The company's lead candidate, AKY-1189, is a miniprotein radioconjugate targeting Nectin-4, the same protein that Pfizer's bladder cancer drug Padcev binds to. Aktis's approach uses alpha-emitting isotopes which can hit tumor targets outside the scope of other radiopharmaceuticals. A second candidate, Ac-AKY-2519, targets B7-H3 expressing tumors with an IND filing planned for 2026.
Competitive Landscape 2025–2026
Aktis's IPO ranks as the sector's third-largest since the start of 2024, trailing only offerings from Kyverna Therapeutics and CG Oncology, and its successful debut signals renewed public market interest in companies with differentiated platforms and clear clinical milestones in precision oncology.
Key Differentiators
Strong Challenger
Aktis Oncology is an established challenger with significant market presence and competitive offerings in Healthcare & Life Sciences.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
Revvity
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid
GE HealthCare
GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designin
Compare Aktis Oncology with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Aktis Oncology? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Aktis Oncology Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Aktis Oncology vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →